Utility of ELISA Optical Density Values and Clinical Scores for the Diagnosis of and Thrombosis Prediction in Heparin-induced Thrombocytopenia

被引:12
作者
Kim, Seon Young [1 ]
Kim, Hyun Kyung [1 ]
Han, Kyou Sup [1 ]
Kim, Inho [2 ]
Yoon, Sung-Soo [2 ]
Park, Seonyang [2 ]
Kim, Byoung Kook [2 ]
机构
[1] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul 110744, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea
来源
KOREAN JOURNAL OF LABORATORY MEDICINE | 2011年 / 31卷 / 01期
关键词
Heparin-induced thrombocytopenia; Heparin-platelet factor 4 antibody; Clinical scoring system; Optical density value; ANTIBODIES; IMMUNOASSAYS; PROBABILITY; RECOGNITION; PREVENTION;
D O I
10.3343/kjlm.2011.31.1.1
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
100118 [医学信息学]; 100208 [临床检验诊断学];
摘要
Background: Heparin-induced thrombocytopenia (HIT) is an adverse drug reaction caused by antibodies to the heparin/platelet factor 4 (PF4) complex, resulting in thrombocytopenia and prothrombotic state. HIT diagnosis is challenging and depends on clinical presentation and laboratory tests. We investigated the usefulness of clinical scores and heparin/PF4 ELISA optical density (OD) as a diagnostic marker and thrombosis predictor in HIT. Methods: We analyzed 92 patients with suspected HIT. The heparin/PF4 antibody was measured using a commercial ELISA kit (GTI, USA). For each patient, the 4 T's score and Chong's score were calculated. Results: Of the 92 patients, 28 were anti-heparin/PF4-seropositive. The 4 T's score and Chong's score showed good correlation (r=0.874). The 4 T's score and OD values showed good performance for diagnosis of the definite and unlikely HIT groups; however, OD levels showed better sensitivity (93.8%) than the 4 T's score used alone (62.5%). Of the 92 patients, 26 developed thrombosis. The OD values were significantly higher in patients with thrombosis than in those without thrombosis (0.52 vs. 0.22, P<0.001). Patients with high OD values (OD > 0.4) had an increased risk of thrombosis (adjusted odds ratio 9.44 [3.35-26.6], P<0.001) and a shorter 250-day thrombosis-free survival (32.1% vs. 54.7%, P=0.012). Conclusions: ELISA OD values in combination with clinical scoring can improve the diagnosis of and thrombosis prediction in HIT. More attention should be paid to the use of clinical scores and OD values as thrombosis predictors in HIT.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 16 条
[1]
Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia [J].
Bakchoul, T. ;
Giptner, A. ;
Najaoui, A. ;
Bein, G. ;
Santoso, S. ;
Sachs, U. J. H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) :1260-1265
[2]
Timely diagnosis and management of heparin-induced thrombocytopenia in a frequent request, low incidence single centre using clinical 4T's score and particle gel immunoassay [J].
Bryant, Adam ;
Low, Joyce ;
Austin, Steven ;
Joseph, Joanne E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (05) :721-726
[3]
Chong Beng H, 2004, Expert Rev Cardiovasc Ther, V2, P547, DOI 10.1586/14779072.2.4.547
[4]
Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes [J].
Greinacher, A. ;
Juhl, D. ;
Strobel, U. ;
Wessel, A. ;
Lubenow, N. ;
Selleng, K. ;
Eichler, P. ;
Warkentin, T. E. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (08) :1666-1673
[5]
Recognition, treatment, and prevention of heparin-induced thrombocytopenia: Review and update [J].
Greinacher, Andreas ;
Warkentin, Theodore E. .
THROMBOSIS RESEARCH, 2006, 118 (02) :165-176
[6]
Usefulness of optical density values from neparin-platelet factor 4 antibody testing and probability scoring models to diagnose heparin-induced thrombocytopenia [J].
Janatpour, Kim A. ;
Gosselin, Robert C. ;
Dager, William E. ;
Lee, Andrew ;
T Owings, John ;
Zhou, Jufen ;
Wun, Ted .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (03) :429-433
[7]
Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings [J].
Lo, GK ;
Juhl, D ;
Warkentin, TE ;
Sigouin, CS ;
Eichler, P ;
Greinacher, A .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) :759-765
[8]
Thrombotic events in patients with antiplatelet factor 4/heparin antibodies [J].
Mattioli, A. V. ;
Bonetti, L. ;
Carletti, U. ;
Ambrosio, G. ;
Mattioli, G. .
HEART, 2009, 95 (16) :1350-1354
[9]
Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays [J].
Warkentin, T. E. ;
Sheppard, J. I. ;
Moore, J. C. ;
Sigouin, C. S. ;
Kelton, J. G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (08) :1304-1312
[10]
Impact of the patient population on the risk for heparin-induced thrombocytopenia [J].
Warkentin, TE ;
Sheppard, JAI ;
Horsewood, P ;
Simpson, PJ ;
Moore, JC ;
Kelton, JG .
BLOOD, 2000, 96 (05) :1703-1708